Nirupama Sista

3.3k total citations
14 papers, 459 citations indexed

About

Nirupama Sista is a scholar working on Infectious Diseases, Oncology and Epidemiology. According to data from OpenAlex, Nirupama Sista has authored 14 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Nirupama Sista's work include HIV/AIDS Research and Interventions (7 papers), Viral-associated cancers and disorders (6 papers) and HIV, Drug Use, Sexual Risk (5 papers). Nirupama Sista is often cited by papers focused on HIV/AIDS Research and Interventions (7 papers), Viral-associated cancers and disorders (6 papers) and HIV, Drug Use, Sexual Risk (5 papers). Nirupama Sista collaborates with scholars based in United States, South Africa and Zimbabwe. Nirupama Sista's co-authors include Joseph S. Pagano, Albert Liu, Jared M. Baeten, Jessica E. Haberer, Chaojie Liu, Wenlin Liao, Shannon C. Kenney, Jeffrey L. Wilson, Christopher T. Barry and Quarraisha Abdool Karim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Molecular and Cellular Biology.

In The Last Decade

Nirupama Sista

13 papers receiving 450 citations

Peers

Nirupama Sista
Duo Shan China
Wensheng Fan China
D. Peter Drotman United States
Mark Milazzo United States
Estela Luz Brazil
Lee Lam United States
Pamela P. Gumbi South Africa
Delphine Rapoud France
Tae Joon Yi Canada
Duo Shan China
Nirupama Sista
Citations per year, relative to Nirupama Sista Nirupama Sista (= 1×) peers Duo Shan

Countries citing papers authored by Nirupama Sista

Since Specialization
Citations

This map shows the geographic impact of Nirupama Sista's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nirupama Sista with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nirupama Sista more than expected).

Fields of papers citing papers by Nirupama Sista

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nirupama Sista. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nirupama Sista. The network helps show where Nirupama Sista may publish in the future.

Co-authorship network of co-authors of Nirupama Sista

This figure shows the co-authorship network connecting the top 25 collaborators of Nirupama Sista. A scholar is included among the top collaborators of Nirupama Sista based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nirupama Sista. Nirupama Sista is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bekker, Linda‐Gail, Subash Pathak, Elizabeth E. Tolley, et al.. (2020). Safety and tolerability of injectable Rilpivirine LA in HPTN 076: A phase 2 HIV pre-exposure prophylaxis study in women. EClinicalMedicine. 21. 100303–100303. 16 indexed citations
2.
Tillotson, Joseph, Linda‐Gail Bekker, Sue Li, et al.. (2020). Metabolism of Long-Acting Rilpivirine After Intramuscular Injection: HIV Prevention Trials Network Study 076 (HPTN 076). AIDS Research and Human Retroviruses. 37(3). 173–183. 2 indexed citations
3.
Sista, Nirupama, Wafaa El‐Sadr, David Serwadda, & Myron S. Cohen. (2020). HIV Prevention: Great Achievements, More Challenges Ahead. UNC Libraries.
4.
Tolley, Elizabeth E., Sue Li, Sahar Z. Zangeneh, et al.. (2019). Acceptability of a long‐acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076). Journal of the International AIDS Society. 22(10). e25408–e25408. 42 indexed citations
5.
Mastro, Timothy D., Nirupama Sista, & Quarraisha Abdool Karim. (2014). ARV‐based HIV prevention for women – where we are in 2014. Journal of the International AIDS Society. 17(3S2). 19154–19154. 15 indexed citations
6.
Baeten, Jared M., Jessica E. Haberer, Albert Liu, & Nirupama Sista. (2013). Preexposure Prophylaxis for HIV Prevention. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(Supplement 2). S122–S129. 126 indexed citations
7.
El‐Sadr, Wafaa, David Serwadda, Nirupama Sista, & Myron S. Cohen. (2013). HIV Prevention. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(Supplement 2). S115–S116. 9 indexed citations
8.
Sista, Nirupama, et al.. (2011). Experience in international clinical research: the HIV Prevention Trials Network. Clinical Investigation. 1(12). 1609–1618. 11 indexed citations
9.
Liu, Chaojie, Nirupama Sista, & Joseph S. Pagano. (1996). Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F. Journal of Virology. 70(4). 2545–2555. 62 indexed citations
10.
Sista, Nirupama, et al.. (1995). Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR  and RXR . Nucleic Acids Research. 23(10). 1729–1736. 35 indexed citations
11.
Sista, Nirupama, et al.. (1994). Reciprocal Regulation of the Epstein-Barr Virus BamHI-F Promoter by EBNA-1 and an E2F Transcription Factor. Molecular and Cellular Biology. 14(11). 7144–7152. 25 indexed citations
12.
Wilson, Jeffrey L., et al.. (1994). Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor.. Molecular and Cellular Biology. 14(11). 7144–7152. 44 indexed citations
13.
Sista, Nirupama, Joseph S. Pagano, Wenlin Liao, & Shannon C. Kenney. (1993). Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.. Proceedings of the National Academy of Sciences. 90(9). 3894–3898. 45 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Duo Shan Breakdown of academic impact, for papers by Wensheng Fan Breakdown of academic impact, for papers by D. Peter Drotman Breakdown of academic impact, for papers by Mark Milazzo Breakdown of academic impact, for papers by Estela Luz Breakdown of academic impact, for papers by Lee Lam Breakdown of academic impact, for papers by Pamela P. Gumbi Breakdown of academic impact, for papers by Delphine Rapoud Breakdown of academic impact, for papers by Tae Joon Yi
Rankless by CCL
2026